entertainment -WSS

entertainment

author：leisure time 2025-08-12 08:29:17 - browse：7839

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Walmart eyes Medicare Advantage provider ChenMed

explore

WSS

Medicare has a new plan to address drug shortages

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Telehealth for opioid use disorder is lifesaving

Pig kidney works a record two months in donated body

Google and Epic fight stronger regulation of AI in health care

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

focus

entertainment

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Telehealth for opioid use disorder is lifesaving

Trump demands the U.S. pay no more for drugs than other countries … again

Private equity could exacerbate cardiology's overuse problem, experts fear

Drug repurposing or repositioning? The language matters

Sanders adds drug shortage policies to pandemic preparedness bill

The cancer drug shortage isn’t new — and neither are the solutions

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Custom gene therapy hints at new path for rare disease treatments

focus

PEPFAR is under serious threat — and so is global health

How medical schools plan to diversify without affirmative action

Will the IRA bring competition to the biologics market?

Group opposing PBM reform sets lobbying record

How Medicaid coverage policies for immigrants impact new moms

Private equity could exacerbate cardiology's overuse problem, experts fear

explore

explore

focus

hotspot